Literature DB >> 10658728

Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.

G L Bennett1, A Petersein, W W Mayo-Smith, P F Hahn, W Schima, S Saini.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the addition of gadolinium-enhanced imaging to heavily T2-weighted MR imaging of the liver is valuable in differentiating hemangiomas from metastases. The T2 relaxation time was also included in our analysis. SUBJECTS AND METHODS: Fifty-one patients with 52 proven liver lesions (24 hemangiomas and 28 metastases) larger than 1 cm underwent MR imaging at 1.5 T with T2-weighted spin-echo (TR/TE, 3000/80, 160) and gadolinium chelate-enhanced dynamic T1-weighted gradient-recalled echo (80/2.6, 80) pulse sequences. Images were reviewed by observers who were unaware of the patients' clinical history; first, only T2-weighted images were reviewed and then T2-weighted plus dynamic images were reviewed together. The T2 relaxation times were calculated for each lesion. Diagnostic accuracy by each method was compared using receiver operating characteristic analysis.
RESULTS: Mean T2 relaxation times were 76 +/- 26 msec for metastases and 133 +/- 25 msec for hemangiomas. The addition of dynamic scanning to the T2-weighted sequence made a statistically significant difference for only one observer (p = 0.03). However, it did not make a statistically significant contribution for either observer when compared with the T2 relaxation time. Although addition of the dynamic images resulted in correct diagnosis of six lesions, three lesions were misdiagnosed after having been correctly characterized on the T2-weighted images alone.
CONCLUSION: When optimized T2-weighted images are obtained and the T2 relaxation time is calculated, routine use of gadolinium enhancement for differentiation of hemangiomas from metastases is unnecessary although dynamic scanning is valuable in selected cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658728     DOI: 10.2214/ajr.174.2.1740477

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.

Authors:  Song-Ee Baek; Mi-Suk Park; Hye Sook Hong; Jin Young Choi; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2010-07-09       Impact factor: 5.315

2.  Atypical hemangioma mimicking hepatocellular carcinoma with a special note on radiological and pathological findings.

Authors:  Masakatsu Tsurusaki; Ryota Kawasaki; Masato Yamaguchi; Koji Sugimoto; Takumi Fukumoto; Yonson Ku; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

3.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

Review 4.  Imaging diagnosis of colorectal liver metastases.

Authors:  Ling-Hui Xu; San-Jun Cai; Guo-Xiang Cai; Wei-Jun Peng
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

Review 5.  Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis.

Authors:  Filipe Caseiro-Alves; Jorge Brito; Antonio Eiras Araujo; Pedro Belo-Soares; Henrique Rodrigues; Augusta Cipriano; Daniel Sousa; Didier Mathieu
Journal:  Eur Radiol       Date:  2007-01-27       Impact factor: 5.315

6.  Application of an artificial neural network to the computer-aided differentiation of focal liver disease in MR imaging.

Authors:  Xuejun Zhang; Masayuki Kanematsu; Hiroshi Fujita; Xiangrong Zhou; Takeshi Hara; Ryujiro Yokoyama; Hiroaki Hoshi
Journal:  Radiol Phys Technol       Date:  2009-05-14

Review 7.  [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].

Authors:  A Ba-Ssalamah; B Happel; J Kettenbach; A Dirisamer; F Wrba; F Längle; W Schima
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 8.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

Review 9.  Non-invasive diagnostic imaging of colorectal liver metastases.

Authors:  Pier Paolo Mainenti; Federica Romano; Laura Pizzuti; Sabrina Segreto; Giovanni Storto; Lorenzo Mannelli; Massimo Imbriaco; Luigi Camera; Simone Maurea
Journal:  World J Radiol       Date:  2015-07-28

10.  Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.

Authors:  Akihiro Tateyama; Yoshihiko Fukukura; Koji Takumi; Toshikazu Shindo; Yuichi Kumagae; Kiyohisa Kamimura; Masayuki Nakajo
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.